Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

BI Forms $134 Million JV with Two China Partners for Foot-and-Mouth Vaccine

publication date: Mar 26, 2018

Boehringer Ingelheim joined with two China animal health companies to form a $134 million JV to address foot-and-mouth disease in pigs, cattle and sheep. BI will contribute its vaccine technology to the JV, which will be located in Xi'an and called Shaanxi Meili Omni-Honesty Animal Health. The JV expects to begin production of the vaccine in 2021. BI will be joined by Beijing KangMu Omni-Honesty Animal Health Products (KMOH), and China Agricultural Vet. Bio. Science and Technology (ZNWT). More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital